Free Trial
NASDAQ:INVO

INVO Bioscience (INVO) Stock Price, News & Analysis

$0.76
-0.04 (-5.03%)
(As of 09/6/2024 ET)
Today's Range
$0.75
$0.80
50-Day Range
$0.74
$1.03
52-Week Range
$0.50
$3.50
Volume
44,722 shs
Average Volume
1.51 million shs
Market Capitalization
$2.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
INVO stock logo

About INVO Bioscience Stock (NASDAQ:INVO)

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

INVO Stock Price History

INVO Stock News Headlines

Why billionaires are wiring money to abandoned towns
A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.
Why Invo BioScience Stock Is Soaring Today
Why billionaires are wiring money to abandoned towns
A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.
Why Is Invo Bioscience (INVO) Stock Up 85% Today?
ASMB Assembly Biosciences, Inc.
INVO Bioscience Inc INVO
See More Headlines
Receive INVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
9/07/2024
Next Earnings (Estimated)
11/11/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:INVO
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

Net Income
$-8,030,000.00
Net Margins
-122.79%
Pretax Margin
-122.32%

Debt

Sales & Book Value

Annual Sales
$5.77 million
Book Value
($1.57) per share

Miscellaneous

Free Float
3,676,000
Market Cap
$2.88 million
Optionable
No Data
Beta
1.43
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Steven M. Shum (Age 53)
    CEO & Director
    Comp: $260k
  • Mr. Andrea GorenMr. Andrea Goren (Age 57)
    Chief Financial Officer
    Comp: $215k
  • Mr. Michael Jos. Campbell (Age 66)
    COO & VP of Business Development
    Comp: $220k
  • Mr. Bojan Mitrovic Ph.D.
    Director of Sales US
  • Mr. Robert Joseph Bowdring Jr. (Age 66)
    Treasurer & Secretary
  • Ms. Terah Krigsvold
    Controller

INVO Stock Analysis - Frequently Asked Questions

How have INVO shares performed this year?

INVO Bioscience's stock was trading at $1.35 at the beginning of the year. Since then, INVO shares have decreased by 44.1% and is now trading at $0.7550.
View the best growth stocks for 2024 here
.

How were INVO Bioscience's earnings last quarter?

INVO Bioscience, Inc. (NASDAQ:INVO) announced its earnings results on Wednesday, August, 14th. The company reported ($0.62) EPS for the quarter. The company earned $1.84 million during the quarter.

When did INVO Bioscience's stock split?

INVO Bioscience shares reverse split before market open on Thursday, July 27th 2023. The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of INVO Bioscience?

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INVO) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners